ClinicalTrials.gg
Not yet recruitingNCT06475248Updated Jun 25, 2026

Influence of Osteopathic Intervention on Cervical Muscles in Tension Headaches in Women

An interventional study of Placebo Technique and Stretching technique in Tension Headaches, sponsored by Escola Superior de Tecnologia da Saúde do Porto. Not yet recruiting at 1 site in Portugal. Open to female participants aged 18 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-06-25.

Sponsored by Escola Superior de Tecnologia da Saúde do Porto · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
43
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
Female
01

Study summary

This study aims to understand whether there is any relationship between the intervention on the trapezius, sternocleidomastoid and suboccipital muscles in patients with chronic tension headaches.

Read the detailed description

It is expected to find an improvement in the symptoms and frequency of tension headaches.

In this study, the investigators intend to see the effects of trapezius and sternocleidomastoid "stretching techniques", and "suboccipital inhibition" on tension headaches. To collect data, volunteers were asked to fill out the Headache Impact Test (HIT-6).

02

Conditions studied

  • Tension Headaches

Browse trials for

Keywords

  • Tension headaches
  • Trapezius Stretching
  • sternocleidomastoid Stretching
  • Suboccipital Inhibition
  • Manual Therapy
  • Osteopathy
  • HIT-6
03

In context

Tension-Type Headache

144 studies on the registry are indexed under Tension-Type Headache; 42 are open to participants now.

This study's planned enrollment of 43 is below the median of 60 across 109 interventional studies indexed under Tension-Type Headache.

Browse Tension-Type Headache studies →

Lead sponsor

Escola Superior de Tecnologia da Saúde do Porto is the lead sponsor of 39 studies on the registry; 20 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Tension headaches;
  • Being over eighteen years of age;

Exclusion criteria

Exclusion Criteria:

  • Loss of mobility of cervical;
  • Cervical and shoulder pain during episodes;
  • Other headaches (migraine, cervicogenic headache...)
  • Other interventions and/or pharmacological treatment a few days before the intervention;
  • Epilepsy;
  • Trauma.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
43 participants (estimated)

Study arms

  • Placebo comparator
    Control Group

    Each volunteer selected in this group will complete a scale, in this case Hit-6, to collect data and evaluate the evolution. Then a placebo technique will be used, which consists of imitating the contacts of the techniques without compressing or pulling the tissue, lasted 6 minutes. This procedure will be repeated for two more sessions. One month after the first evaluation, the volunteers filled out the Hit-6 scale again.

    Other: Placebo Technique

  • Experimental
    Experimental Group

    After each volunteer completes the Hit-6 scale, one of the researchers will perform the "trapezius and sternocleidomastoid stretching techniques", and "suboccipital inhibition". The techniques performed will only be done once, lasted 6 minutes. This procedure will be repeated for two more sessions. One month after the first evaluation, the volunteers filled out the Hit-6 scale again.

    Other: Stretching technique · Other: Inhibition of the suboccipital

Interventions

  • OtherPlacebo Technique

    For the technique performed in the control group, the researcher will come into contact with the volunteers' chests. This contact will be maintained for the same period of time as the experimental group (6 minutes).

  • OtherStretching technique

    "Stretching technique" for the upper trapezius and sternocleidomastoid: the volunteer will be in supine position on the couch, the researcher will perform the technique from the contralateral side of the muscle to be treated, the hand will contact the ipsilateral shoulder to stabilize, meanwhile, with the other hand, contact the upper trapezius and perform a rhythmic pull in contralateral rotation. This technique is performed bilaterally.

  • OtherInhibition of the suboccipital

    "Inhibition of the suboccipital": the participant is in the supine position, the researcher will position himself behind the patients head. In this technique, contacts will be made on the suboccipital area with the 2nd, 3rd and 4th fingers of both hands. Make a slight pull with your body backwards and wait that there is relaxation of muscular tensions.

06

What researchers measure

Primary outcomes

  1. Change in the intensity and frequency of pain after the three treatment sessions;

    The scale Hit-6 will be the instrument used to evaluate the level the intensity and frequency of tension headache. This instrument consists of six questions about the characteristics of headaches, with each question presenting five choices. The answers range from never to always. This data will be collected immediately before the first investigation and one month after the first evaluation, through the volunteers filling out the scale.

    Time frame: One month after the first intervention

07

Study locations

1 site
08

References and documents

Publications

  • Cumplido-Trasmonte C, Fernandez-Gonzalez P, Alguacil-Diego IM, Molina-Rueda F. Manual therapy in adults with tension-type headache: A systematic review. Neurologia (Engl Ed). 2021 Sep;36(7):537-547. doi: 10.1016/j.nrleng.2017.12.005. Epub 2020 Apr 7. PubMed 34537167 ↗
  • Lebedeva ER, Kobzeva NR, Gilev DV, Olesen J. The quality of diagnosis and management of migraine and tension-type headache in three social groups in Russia. Cephalalgia. 2017 Mar;37(3):225-235. doi: 10.1177/0333102416642603. Epub 2016 Jul 11. PubMed 27053061 ↗
  • Hartman, L. S. (2013). Handbook of osteopathic technique. Springer
09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Sep 2026; primary completion for Dec 2026, 3 months later.

Of 50 non-industry interventional studies with no phase under Tension-Type Headache, half reached primary completion within 9 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 32. This study's planned 3 months is below that.

Counting every sponsor, half of 50 studies reached it within 9 months; a quarter within 3 and three quarters within 32.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 20, 2024
First posted
Jun 26, 2024
StartEst.
Sep 2026
Primary completionEst.
Dec 2026
CompletionEst.
Dec 11, 2026
Last update
Jun 25, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 25, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06475248
Lead sponsor
Escola Superior de Tecnologia da Saúde do Porto
Responsible party
Natália Maria Oliveira Campelo (Investigator, Escola Superior de Tecnologia da Saúde do Porto) — Principal investigator
First posted
Jun 26, 2024
Start date
Sep 2026 (estimated)
Primary completion
Dec 2026 (estimated)
Completion
Dec 11, 2026 (estimated)
Last update
Jun 25, 2026

Study contacts

Natália MO Campelo, PhD
Contact
nmc@ess.ipp.pt
+35122 206 1000
Natália MO Campelo, PhD
principal investigator · Escola Superior da Saúde do Porto

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion